OrbiMed Capital GP V LLC, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 35,000 shares at $12.71 ($434K) on 2016-06-14, disclosed to the SEC on 2016-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.71 | 10,000 | $127K | 29.3% |
| 2 | $12.71 | 10,000 | $127K | 29.3% |
| 3 | $11.94 | 5,000 | $60K | 13.7% |
| 4 | $12.04 | 5,000 | $60K | 13.9% |
| 5 | $12.04 | 5,000 | $60K | 13.9% |
| Total | $12.41 avg | 35,000 |
| $434K |
| 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |